Kuantum Paper - Strong Turnaround

Located in Punjab, Kuantum Papers (known as ABC paper till 2012 until the name was changed) is an agro based paper manufacturer in India and manufactures primarily maplitho, creamwove, copier and specialty paper with a GSM range of 40-200 GSM. It has an operating capacity of 160,000 MTPA.

Client list includes Camlin Kokuyo, Mcgrawhill, S Chand, Navneet Publications among others. Caters primarily to academic segment.

The company’s major area of operations lie within 1,000 kms of the plant (in Punjab) in Northern and Eastern India. 32% revenues from Delhi, 10% Haryana, 7% from J&K, 7% from UP, 7% Punjab. Manufacturing is done based on pre-orders from its 100+ dealer network leading to low working capital days at 37 days.

In 2019, the company had undertaken a backward integration and modernization project involving a capex of 440 cr. The project was focused on cost optimization in generating captive power and in a chemical recovery boiler where the waste material from the pulping process was to be retreated to produce caustic soda which is an input in the pulping process).

Subsequently as the pandemic took hold and use of paper especially related to academia fell off a cliff. Revenues fell 60-70% in H1FY21. Due to the capex plan undertaken in 2019 and the pandemic taking hold, the company faced financial difficulties and entered into a resolution plan with its lenders under “Resolution Plan under RBI’s Framework Covid-19 related Stress” which helped it gain a moratorium on debt payments till Aug 2022 and regularization of some outstanding loans which would otherwise have been classified as default.

Coming to present day, Kuantum paper has recovered smartly from the Covid lows with revenues (Rs 1310 cr in FY23) up 60% from pre-covid levels. Company is operating at close to 100% capacity utilization with plans to increase capacity by 25% in coming fiscal. Increase in FY23 revenues can be attributed to increased volumes (+20% from pre covid levels) and the rest can be attributed to better realizations.

FY23 OPM came in at 29% of revenues for FY23 but has historically varied between 12-21%. Margin increase has been on the back of increased realization. Management seems to be confident of achieving 33% margins (paste screenshot) in FY25 due to certain investments worth Rs 285 cr being made in capacity expansion, a new tissue paper manufacturing plant and captive power generation.

I have my doubts on this guidance as I would expect paper prices to behave in tandem with pulp prices. Wood pulp prices from China had reached a peak of $1200 per ton and have corrected to $800 levels towards end 2022 but the price of paper has not declined in line with pulp prices this time as per management.

Management is confident of achieving the targeted margins even if realizations fall off

Company has aggressively paid down loans in view of the uptick in financial performance and as on Mar 2023 has debt which is Rs 60 cr lower than what it would have been had the company stuck to the original repayment schedule as agreed with the lenders.

Key Positives

  • Strong turnaround post COVID
  • Margins have doubled compared to historical average and management is confident of taking it even higher.
  • Company is paying down debt aggressively. Any reduction in debt should ultimately show up in book value.
  • 100% capacity utilization for the last 4 quarters with plans to ramp up capacity by 25% by FY24.
  • Company planning to enter manufacture of food grade wrapping paper which is expected to get a fillip post the ban of single-use plastic

Key Risks

  • Cyclical industry with prices fluctuating in line with pulp prices. Although pulp prices have come off by one third in the last one year, they are still 30% above pre-covid levels.
  • Price has already run up in line with financial performace and is traidng at 1.4 P/B and 7.5 P/E (after adjusting earnings for exceptional Rs 64 cr non cash item in FY23) which is in line with market leaders like JK Paper, Andhra Paper and at a premium to TNPL

Disclosure: Not invested. Evaluating

5 Likes

SALES VOLUME FOR PAST TWO YEARS -

FY 22 - 151674 MT
FY 23 - 152304 MT

The volume has only increased by little but the Sales figure in rupees has jumped. It is basically due to increase in prices but for the company to grow it needs to increase its sales volume.

1 Like

They have a capacity of 160000 MT and are in the process of raising it by 25% to 200000 MT. From what I read, I think most of the increased capacity should be operational around mid FY24

also focus on debt reduction…a year and half more of these high margins…and debt will be history in this company. The promoter pledge will also go down with flow of dividends. So a potential change in perception awaits this company.

disclosure: invested at lower level

To add to the story of Kuantum you have narrated, they have also established a pilot bio ethanol plant from wood pulp and agri waste. The management has time and again underplayed this development

However, there is a separate company, Khaitan bio energy (Link)

It seems that operations related to ethanol will be handled by Khaitan bio energy. It remains to be seen whether the same company will be a subsidiary of Kuantum Papers or it will be held privately by the Khaitan family.

2 Likes

what gives them the competitive edge over its peers?

This is similar to Satia Industries …there are few differences like clientele etc…

An update on this ethanol story - Found this piece of information on public domain. The khaitan bio energy which was mentioned in the previous post is held privately by the Khaitan family. Attached screenshot :

Also there was no follow up update on the ethanol story in this year’s annual report. The piece almost vanished in thin air.
Earlier, in 2023 annual report there was a half page writeup on the ethanol story with a mention of creating a SPV and a concluding statement that read -

image

This was a bet on paper companies venturing into ethanol production, anticipating a boom similar to the sugar industry. However, it appears the management intends to keep the benefits to themselves for now.
Disc: Squared my position.

2 Likes

Kuantum Paper has currently became a very interesting case. It is currently trading around 76 rs per share. Business has been into downcycle from last two years as we can clearly see (FY 2025 & FY 2026).

Interestingly, we can see now paper cycle is turning now and it visible in OPM% on recent quarters. Also management has indicated same in Feb 2026 concall.

Capex:
Kuantum paper will be completing its planned capex in June 2026. There is very marginal Hit on revenue due to this capex.

Debt:

They will have Debt of around 750 crores at peak. Interest will be paid around 30 crores per quarter.

Management is looking to prepay the debt before time. They have done same in past in ‘22-’23 during up cycle.

Going Forward:

Management is giving target of about 1,800 crores revenue and EBITDA of 300 crores for FY-27 on annualized basis. This revenue guidance is more than 50% higher than FY 26 revenue of 1,093 crores. Management says if the Price hike didn’t happened than they can do 1,500 crores sales on Volume basis alone. Including Price hike they can achieve 1,800 crores sales. It is very evident from OPM% of recent quarters that there are signs of cycle turning now.

Management of S Chand & Company Ltd also saying that there will be price hike this year of at least 10% to 15% .

Valuation (as on 29-May-2026):

Stock is trading at Market cap = 660 crores (approx). Does it should trade at such low valuation when sales next year will around 1700-1800 crores with EBITDA of around 300 crores. Also, cycle turning Up is also visible now.

Please share your views Investors. Please correct me if I am wrong somewhere.
**
Disclosure: Invested at current levels.**

2 Likes

As per Latest Concall (Q4-FY26/FY26 earnings), PM3 upgradation is delayed. Its was planned for May 2026 and now management will plan for mid June 2026.

Revenue target still Intact for FY27 around 1400-1500 crores. For FY28 is 1800 crores

Company is able to maintain pricing at healthy level.

1 Like

probably not going to reach those high EBITDA levels next year but here is my take on it.
Paper stocks are cyclical - overcapacity → some go bust → strong demand comes in → margins improve before new capacity is triggered
I have been watching, and buying/selling this name since 2021 and that’s where the stock price is today. But there are more reasons to it than just cyclicality. The industry has been struggling with cheaper imports from SE Asia and price of RM (wood chips and agri outputs) have gone up substantially. Although the association has written to the govt regarding cheap imports, that study and action takes 1-2 years as stated by Mr Pavan Khaitan. So the margins heavily depend on this anti dumping kicking in, probably by the end of FY 27. RM price shot up as soon as the war began and fears of shortage of LPG as the same RM is used by many in cooking needs. For supply chain of LPG to go back to normal level, it might take time, probably by end of FY 27. This is also true for some of their chemical imports which might see some drop from the war highs. This double whammy on Kuantum drove down stock price. Another big impact was the GST change on notebook and they are exiting the notebook segment entirely which will bring down NSR. Further there was some delay in machine upgradation.
The company is setting target for 25-30% capacity for specialty paper that should increase the NSR and their investment in DDS unit will only make the margins better. Finer details to this remains undisclosed though.
I personally think downside is protected since mcap is hovering around 0.5x BV but a genuine recovery is little far than one would expect.

1 Like

For some fast kind of measures, management has also submitted anti subsidy application as well which works faster.